1. General Requirements on Content and of Labeling for Human Prescription Drugs. 21 Code of Federal Regulations Sect. 201.56 (2000). Available at: http://www.access.gpo.gov/nara/cfr/waisidx_00/21cfr201_00.html. [11 November 2000].
2. Specific Requirements on Content and Format of Labeling for Human Prescription Drugs. 21 Code of Federal Regulations Sect. 201.57(j) (2000) Available at: http://www.access.gpo.gov/nara/cfr/waisidx_00/21cfr201_00.html. [11 November 2000].
3. US Food and Drug Administration. Index of Safety-related Drug Labeling Change Summaries Approved by FDA. Available at: http://www.fda.gov/../medwatch/safety/1999/index99.htm. [19 January 2001].
4. World Health Organization Collaborating Centre for Drug Statistics Methodology. Available at: http://www.whocc.nmd.no/DDs_alterations.htm. [17 January 2001].
5. Dose Discrepancies Between the Physicians' Desk Reference and the Medical Literature, and Their Possible Role in the High Incidence of Dose-Related Adverse Drug Events